Bharat Biotech has sought India’s drug regulator DCGI’s approval to extend the shelf life of it’s Covid-19 vaccine Covaxin from six months to 24 months and has hence written a letter to the functionary body on Sunday, reports TOI.
Explore the profound effects of excessive screen time on your child’s behavior and development. Discover…
Discover how simple daily changes in your diet and lifestyle can significantly improve your heart…
This article explores the common misconception that brain tumours primarily affect older adults, revealing the…
The first-ever ovarian cancer vaccine is poised to change the landscape of women's health by…
As dengue and chikungunya cases rise in Delhi during the monsoon season, understanding prevention strategies…
Skincare is a significant concern for women (and increasingly, men), with the quest for perfect,…